Windtree Therapeutics Inc
WINT- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000946486
No open-market purchases or sales by Windtree Therapeutics Inc insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Holders of 5% or more of WINT
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Windtree Therapeutics Inc, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Windtree Therapeutics Inc on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
2 Schedule 13D and 13G filings on Windtree Therapeutics Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 14, 20254:44 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 2.55%288.6K shares | –Below 5% | Dec 31, 2024 | SEC |
| Jan 10, 2022 | Center Laboratories, Inc. | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Windtree Therapeutics Inc shares.
No Form 144 notices for Windtree Therapeutics Inc are on file.